Why pharma firms are betting billions on psychedelic drugs despite setbacks

Paper. Peeples L. Nature, 1 Oct 2026.

Weekly Science Digest, 23 Oct 2026 to 29 Oct 2026, finding 5: In brief

Nature news feature on why pharma keeps committing billions to psychedelics after a run of regulatory and trial setbacks